Evidence map›Paper›PMID 24236206›Full record

ArticlePloS one2013

The caveolin-1 scaffolding domain peptide decreases phosphatidylglycerol levels and inhibits calcium-induced differentiation in mouse keratinocytes.

Haixia Qin, Wendy B Bollag

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Disruption of Hepatic Insulin Signaling Causes Phospholipid Dysregulation in Mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Review
  4. Involvement of caveolin-1 in skin diseases.Frontiers in immunology · 2022
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Lipid rafts and detergent-resistant membranes in epithelial keratinocytes.Methods in molecular biology (Clifton, N.J.) · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Haixia QinDepartment of Physiology, Medical College of Georgia at Georgia Regents University, Augusta, Georgia, United States of America.
Wendy B Bollag
Augusta University · USGeorgia Regents Medical Center · US

Funding

PHOSPHOLIPASE D AND KERATINOCYTE DIFFERENTIATIONR01AR045212 · NIAMS · MEDICAL COLLEGE OF GEORGIA (MCG) · PI BOLLAG, WENDY B · 1999 to 2007
$1.1M
PHOSPHOLIPASE D AND KERATINOCYTE DIFFERENTIATIONR29AR045212 · NIAMS · MEDICAL COLLEGE OF GEORGIA (MCG) · PI BOLLAG, WENDY B · 1998 to 1998
–
NIAMS NIH HHS AR45212NIAMS NIH HHS R01 AR045212
6 · The paper itself

Abstract

Phospholipase D2 (PLD2) has been found localized in low-density caveolin-rich membrane microdomains. Our previous study suggested that PLD2 and aquaporin 3 (AQP3) interact in these domains to inhibit keratinocyte proliferation and promote differentiation by cooperating to produce phosphatidylglycerol. To examine the effect of membrane microdomain localization on the PLD2/AQP3 signaling module and keratinocyte proliferation and differentiation, we treated mouse keratinocytes with 3 µM cell-permeable caveolin-1 scaffolding domain peptide or a negative control peptide and stimulated cell differentiation using a moderately elevated extracellular calcium concentration (125 uM) to maximally promote differentiation and phosphatidylglycerol production. Cell proliferation, differentiation, total PLD activity, phosphatidylglycerol levels, and AQP3 activity were monitored. The caveolin-1 scaffolding domain peptide itself had no effect on phosphatidylglycerol levels or keratinocyte proliferation or differentiation but prevented the changes induced by a moderately elevated calcium concentration, whereas a negative control did not. The caveolin-1 scaffolding domain peptide had little effect on total PLD activity or glycerol uptake (AQP3 activity). We conclude that the caveolin-1 scaffolding domain peptide disrupts the functional association between AQP3 and PLD2 and prevents both the inhibited proliferation and the stimulated differentiation in response to elevated extracellular calcium levels. The interaction of caveolin-1 and PLD2 is indirect (i.e., lipid mediated); together with the proliferation-promoting effects of caveolin-1 knockout on epidermal keratinocytes, we propose that the caveolin-1 scaffolding domain pepetide exerts a dominant-negative effect on caveolin-1 to alter lipid rafts in these cells.

Indexed as

Cell DifferentiationAnimalsCalciumCaveolin 1DNA ReplicationEnzyme ActivationGlycerolGlycerophospholipidsKeratinocytesMicePeptide FragmentsPhosphatidylglycerolsTransglutaminasesCalciumCaveolin 1caveolin-1 (82-101)GlycerolGlycerophospholipidsPeptide FragmentsphosphatidylethanolPhosphatidylglycerolsTransglutaminases

Identifiers

PMID24236206
PMCPMC3827482
OpenAlexW2026541209

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.